| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 不明 |
| 被験者数 | 27 |
| 性別 | 不明 |
この研究の注釈：
A dose of 135mg EGCG, after 45 minutes, resulted in less cerebral blood flow measured in the frontal cortex. A dose of 270mg did not have this effect.
A dose of 135mg EGCG, after 45 minutes, resulted in less cerebral blood flow measured in the frontal cortex. A dose of 270mg did not have this effect.
Capsules had 94% EGCG by weight, 6% excipients. Caffeine content not stated but most likely inconsequential due to low dose.
No adverse effects were seen on cognition or mood.